Elucidating the role of ADN in exercise-mediated antidepressive action under stress would provide new insights for finding biomarkers that objectively indicate the severity of depression and help formulate the individualized exercise plan for neuropsychiatric diseases involving compromised hippocampal neurogenesis and dendritic plasticity. Here, CFD is linked to depressive symptom measurement.